Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,454 | 21,132 | 12,258 | -30,761 | 6,354 |
| Depreciation Amortization | 5,820 | 5,916 | 6,243 | 7,374 | 4,994 |
| Income taxes - deferred | 6,447 | 9,199 | -3,117 | 8,501 | -19,411 |
| Accounts receivable | -1,229 | 15,807 | -1,277 | 13,991 | 31,304 |
| Accounts payable and accrued liabilities | -41 | -3,439 | 3,316 | -4,119 | -21,969 |
| Other Working Capital | -2,716 | -10,802 | 23,754 | -72,836 | 82,473 |
| Other Operating Activity | 14,288 | -8,831 | 454 | -11,130 | -3,619 |
| Operating Cash Flow | $3,115 | $28,982 | $41,631 | $-88,980 | $80,126 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,686 | -27,103 | 7,355 | 1,532 | -2,525 |
| PPE Investments | -5,832 | -8,104 | -1,829 | -4,012 | -15,560 |
| Net Acquisitions | -1,936 | -28,443 | N/A | -2,735 | -11,902 |
| Sale Of Investment | 4,507 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 100 | -1,500 | 0 | -1,379 | -1,103 |
| Investing Cash Flow | $18,525 | $-65,150 | $5,526 | $-6,594 | $-31,090 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,291 | 3,880 | 2,045 | 2,358 | 2,117 |
| Common Stock Repurchased | -13,104 | N/A | N/A | N/A | -110 |
| Financing Cash Flow | $-11,813 | $3,880 | $2,045 | $2,358 | $2,007 |
| Beginning Cash Position | 81,000 | 113,288 | 64,086 | 160,043 | 109,000 |
| End Cash Position | 90,827 | 81,000 | 113,288 | 66,827 | 160,043 |
| Net Cash Flow | $9,827 | $-32,288 | $49,202 | $-93,216 | $51,043 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,115 | 28,982 | 41,631 | -88,980 | 80,126 |
| Capital Expenditure | -5,832 | -8,104 | -1,829 | -4,012 | -15,560 |
| Free Cash Flow | -2,717 | 20,878 | 39,802 | -92,992 | 64,566 |